1. Home
  2. TROO vs MDAIW Comparison

TROO vs MDAIW Comparison

Compare TROO & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROO
  • MDAIW
  • Stock Information
  • Founded
  • TROO 2005
  • MDAIW N/A
  • Country
  • TROO Hong Kong
  • MDAIW United States
  • Employees
  • TROO N/A
  • MDAIW 78
  • Industry
  • TROO Radio And Television Broadcasting And Communications Equipment
  • MDAIW Medical/Dental Instruments
  • Sector
  • TROO Technology
  • MDAIW Health Care
  • Exchange
  • TROO Nasdaq
  • MDAIW Nasdaq
  • Market Cap
  • TROO N/A
  • MDAIW N/A
  • IPO Year
  • TROO N/A
  • MDAIW N/A
  • Fundamental
  • Price
  • TROO $0.66
  • MDAIW $0.96
  • Analyst Decision
  • TROO
  • MDAIW
  • Analyst Count
  • TROO 0
  • MDAIW 0
  • Target Price
  • TROO N/A
  • MDAIW N/A
  • AVG Volume (30 Days)
  • TROO 17.4K
  • MDAIW 35.6K
  • Earning Date
  • TROO 07-22-2025
  • MDAIW 02-27-2025
  • Dividend Yield
  • TROO N/A
  • MDAIW N/A
  • EPS Growth
  • TROO N/A
  • MDAIW N/A
  • EPS
  • TROO N/A
  • MDAIW N/A
  • Revenue
  • TROO $10,073,000.00
  • MDAIW $27,264,000.00
  • Revenue This Year
  • TROO N/A
  • MDAIW N/A
  • Revenue Next Year
  • TROO N/A
  • MDAIW N/A
  • P/E Ratio
  • TROO N/A
  • MDAIW N/A
  • Revenue Growth
  • TROO 182.24
  • MDAIW 44.52
  • 52 Week Low
  • TROO $0.49
  • MDAIW $0.08
  • 52 Week High
  • TROO $4.89
  • MDAIW $0.90
  • Technical
  • Relative Strength Index (RSI)
  • TROO 43.49
  • MDAIW N/A
  • Support Level
  • TROO $0.61
  • MDAIW N/A
  • Resistance Level
  • TROO $0.73
  • MDAIW N/A
  • Average True Range (ATR)
  • TROO 0.05
  • MDAIW 0.00
  • MACD
  • TROO -0.01
  • MDAIW 0.00
  • Stochastic Oscillator
  • TROO 21.43
  • MDAIW 0.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: